Primary Hyperoxaluria - Pipeline Review, H1 2017

Publisher Name :
Date: 15-Mar-2017
No. of pages: 30
Inquire Before Buying

Primary Hyperoxaluria - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Hyperoxaluria - Pipeline Review, H1 2017, provides an overview of the Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline landscape.

Primary hyperoxaluria is a rare condition characterized by recurrent kidney and bladder stones. It results from the overproduction of a substance called oxalate. Symptoms include blood in the urine, pain when urinating, fever, sudden abdominal pain and frequent urge to urinate. Treatment includes Oral preparations of phosphates and diuretics.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Primary Hyperoxaluria - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Primary Hyperoxaluria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 1 and 1 respectively.

Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Primary Hyperoxaluria (Genito Urinary System And Sex Hormones).

- The pipeline guide reviews pipeline therapeutics for Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Primary Hyperoxaluria (Genito Urinary System And Sex Hormones)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Primary Hyperoxaluria (Genito Urinary System And Sex Hormones).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Primary Hyperoxaluria - Pipeline Review, H1 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Primary Hyperoxaluria - Overview
Primary Hyperoxaluria - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Primary Hyperoxaluria - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Primary Hyperoxaluria - Companies Involved in Therapeutics Development
Allena Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
OxThera AB
Primary Hyperoxaluria - Drug Profiles
ALLN-177 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ALLN-230 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ALN-GO1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DCR-PHXC - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Oxabact - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Primary Hyperoxaluria - Dormant Projects
Primary Hyperoxaluria - Discontinued Products
Primary Hyperoxaluria - Product Development Milestones
Featured News & Press Releases
Jan 08, 2014: OxThera Initiates Clinical Trial in Primary Hyperoxaluria
Jun 04, 2013: OxThera Strengthens Patent Portfolio For Orphan Disease
Apr 03, 2008: Pivotal study is being conducted with Oxabact for the treatment of Primary Hyperoxaluria
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Primary Hyperoxaluria, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Primary Hyperoxaluria - Pipeline by Allena Pharmaceuticals Inc, H1 2017
Primary Hyperoxaluria - Pipeline by Alnylam Pharmaceuticals Inc, H1 2017
Primary Hyperoxaluria - Pipeline by Dicerna Pharmaceuticals Inc, H1 2017
Primary Hyperoxaluria - Pipeline by OxThera AB, H1 2017
Primary Hyperoxaluria - Dormant Projects, H1 2017
Primary Hyperoxaluria - Discontinued Products, H1 2017

List of Figures
Number of Products under Development for Primary Hyperoxaluria, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017
  • Global Hemodialysis Concentrates Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-May-2018        Price: US 3480 Onwards        Pages: 100
    Hemodialysis concentrates including... Scope of the Report: This report focuses on the Hemodialysis Concentrates in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications. Market Segment by Manufacturers, this report covers - Fresenius Medical Care - Baxter - B. Braun - Rockwell Medica......
  • Global Hemodialysis Concentrates Market Research Report 2018
    Published: 08-May-2018        Price: US 2900 Onwards        Pages: 230
    This report studies the Hemodialysis Concentrates market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Hemodialysis Concentrates market by product type and applications/end industries. The major players in global Hemodialysis Concentrates market include Fresenius Medical Care Baxter B. Braun Ro......
  • Global and China Peritoneal Dialysis Solution Market Research by Company, Type & Application 2013-2025
    Published: 05-May-2018        Price: US 2000 Onwards        Pages: 99
    Summary Market Segment as follows: By Type - Containing 1.5% Glucose Type - Containing 2.5% Glucose Type - Containing 4.25% Glucose Type By Application - CAPD - APD By Company - Fresenius - Baxter - B. Braun - Terumo - Huaren - CR Double-Crane - Qingshan Likang - Tj Tianan The main contents of the report including: Section 1......
  • Global Peritoneal Dialysis Solution Market Data Survey Report 2025
    Published: 14-Apr-2018        Price: US 1500 Onwards        Pages: 73
    Summary The global Peritoneal Dialysis Solution market will reach Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacit......
  • Global Renal Failure Partnering 2012 to 2018
    Published: 01-Apr-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Renal Failure Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The re......
  • Global Chronic Kidney Disease Partnering 2012 to 2018
    Published: 01-Apr-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Chronic Kidney Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type ......
  • Global Dialysis Partnering 2012-2018
    Published: 01-Apr-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Dialysis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report ......
  • Global Hemodialysis Concentrates Market Professional Survey Report 2018
    Published: 16-Mar-2018        Price: US 3500 Onwards        Pages: 108
    This report studies Hemodialysis Concentrates in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Fresenius - B. Braun - Renacon Pharma - Chief Medical Supp......
  • Contrast Induced Nephropathy - Pipeline Review, H1 2018
    Published: 27-Feb-2018        Price: US 2000 Onwards        Pages: 36
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contrast Induced Nephropathy - Pipeline Review, H1 2018, provides an overview of the Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline landscape. Contrast-induced nephropathy (CIN) is defined as the impairment of renal function (measured as either a 25%increase in serum creatinine (SCr) from baseline or a 0.5 mg/dL (44 ?mol/L) increase in absolute SCr value after 48-72 ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs